Abel's AI Bet Reshapes the Berkshire Story Ahead of This Morning's Filing
Berkshire's Two-Pronged Test: A 57% Rate Request and a Quarterly Report Due Before the Bell
Energy Fuels: A Paper Loss, a Profitable Mine, and a 2028 Deadline That Has to Hold
Amphenol's Record Backlog Faces Its Real Test: Converting Orders Into Revenue
Copacabana Beach hosts Rio Pride on 22 November
Energy Fuels: 320,000 Pounds Sold at $88.90, a $52.4 Million Loss, and a Price Target Cut to $22.50
Healthineers Prepares for Life After Siemens as Diagnostics Unit Takes the Olyrian Name
Amphenol's Record Order Book Meets a Harder Test: Turning Demand Into Revenue
Boston Scientific Aktie: S&P senkt Ausblick auf negativ
CSG's US Army Contract Boost Is Only Half the Story as Granada Probe Widens
Barclays Backs Bloom Energy's Capacity Story Even as It Trims the Price Target
India's Silver Import Window Opens as Coin Sales Halve and London Stocks Build
IonQ's 336% Revenue Surge Wins Buy Ratings, Not Bigger Price Tags
Changdeokgung Palace hosts Donggwol Dongnak from 10 November
Sainte-Chapelle zeigt Le cœur battant am 29. November
Crash-Diäten: 86 Prozent hatten Nebenwirkungen bei extremer Kalorienkur
Am Hoan-Kiem-See startet Vietnams Kulturtag am 21. November
LKQ Aktie: Zwei Verwaltungsräte kaufen Aktien
Sacsayhuamán empfängt den Papst am 15. November
Nio Aktie: Li fordert Gewichtsgrenzen für Elektroautos
Mont Saint-Michel hosts Landsc’Ages until 22 November
Argen-X Aktie: Myositis-Studie trifft Ziel
Odaiba zeigt Dream Yosakoi Matsuri am 7. November
Heidelberg Materials Puts Its Margin Story to the Test as Analysts Split on Price Targets
Lufthansa Beats Estimates on Cost Discipline as Barclays Turns Bullish on Jet Fuel Relief
Heidelberg Materials Wins Fresh Buy Calls as Its Cost-Cutting Pledge Faces a 2028 Deadline
Realty Income Backs $10 Billion Deployment Plan as Analyst Targets Diverge
Lake Issyk-Kul cleanup removed nets on 4 November
IBM's Agent Controls Go Live as NYSE Moves to Delist a 2026 Bond
Titan Trail Run startet im Weinland Stellenbosch am 7. November
Moderna Lifts Full-Year Outlook as R&D Cuts and Blackstone Backing Reshape the Cost Story
Lenzing Completes EUR 300 Million Raise, Pursues Matching Sum as Plant Sales Take Shape